drugset / Trial / NCT00002409

The Effect of Teaching HIV-Infected Patients About HIV and Treatment

NCT00002409

Phase 3 Completed 200 enrolled Glaxo Wellcome
Treatment

Summary

The purpose of this study is to see if an HIV-education course can help under-represented, HIV-infected patients. This study examines the areas of faithfulness to drug regimen, level of HIV in the blood, and health status.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Background Abacavir Other / unclassified 300 mg Oral
Background Lamivudine Other / unclassified 150 mg Oral
Background Zidovudine Small molecule 300 mg Oral